Mirae Asset Global ETFs Holdings
GLUE icon

Mirae Asset Global ETFs Holdings’s Monte Rosa Therapeutics GLUE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$988K Buy
40,923
+5,128
+14% +$96.9K ﹤0.01% 1636
2026
Q1 		$582K Buy
35,795
+10,243
+40% +$196K ﹤0.01% 1811
2025
Q4 		$402K Buy
25,552
+4,287
+20% +$57.8K ﹤0.01% 1992
2025
Q3 		$158K Sell
21,265
-4,256
-17% -$22.5K ﹤0.01% 2451
2025
Q2 		$115K Buy
25,521
+902
+4% +$4.02K ﹤0.01% 2536
2025
Q1 		$114K Sell
24,619
-82
-0.3% -$503 ﹤0.01% 2572
2024
Q4 		$172K Buy
24,701
+2,084
+9% +$15.6K ﹤0.01% 2458
2024
Q3 		$120K Buy
22,617
+6,347
+39% +$32K ﹤0.01% 2627
2024
Q2 		$60.9K Buy
+16,270
New +$83K ﹤0.01% 2739

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mirae Asset Global ETFs Holdings's GLUE Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Monte Rosa Therapeutics (GLUE) stake by 14% in Q2 2026, buying an estimated $96.9K and bringing the position to 40,923 shares worth $988K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Mirae Asset Global ETFs Holdings first reported a position in GLUE in Q2 2024 and has held it in 9 quarters since. 192 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 40,923 shares of Monte Rosa Therapeutics worth $988K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 5,128 Monte Rosa Therapeutics shares in Q2 2026, an estimated $96.9K.
  • Monte Rosa Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1636 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Monte Rosa Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 192 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.